The Contribution of Viral Genotype to Plasma Viral Set-Point in HIV Infection

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Hodcroft, Emma ^a   Hadfield, Jarrod D ^a   Fearnhill, Esther ^b   Phillips, Andrew ^c   Dunn, David ^b   O'Shea, Siobhan ^d   Pillay, Deenan ^c   Leigh Brown, Andrew J ^a   Celia, Aitken ^e   David, Asboe ^f   Anton, Pozniak ^f   Patricia, Cane ^g   Hannah, Castro ^b   David, Dunn ^b   Esther, Fearnhill ^b   Kholoud, Porter ^b   David, Chadwick ^h   Duncan, Churchill ⁱ   Duncan, Clark ^j   Simon, Collins ^k   Valerie, Delpech ^g   Samuel, Douthwaite ^l   Anna, Maria Geretti ^m   Antony, Hale ⁿ   Stéphane, Hué ^c   Steve, Kaye ^o   Paul, Kellam ^p   Linda, Lazarus ^g   Andrew, Leigh Brown ^a   Tamyo, Mbisa ^g   Nicola, Mackie ^q   Chloe, Orkin ^j,ag   Eleni, Nastouli ^p   Deenan, Pillay ^c,p   Andrew, Phillips ^p   Caroline, Sabin ^p   Erasmus, Smit ^r   Kate, Templeton ^s   Peter, Tilston ^t   Daniel, Webster ^u   Ian, Williams ^c   Hongyi, Zhang ^v   Mark, Zuckerman ^w   Jonathan, Ainsworth ^x   Sris, Allan ^y   Jane, Anderson ^z   Abdel, Babiker ^b   Martin, Fisher ⁱ   Richard, Gilson ^p   Mark, Gompels ^ab   Phillip, Hay ^ac   Teresa, Hill ^p   Margaret, Johnson ^u   Stephen, Kegg ^ad   Clifford, Leen ^ae   Fabiola, Martin ^af   Adrian, Palfreeman ^ah   Jillian, Pritchard ^ak   Frank, Post ^al   Memory, Sachikonye ^aj   Achim, Schwenk ^x   Anjum, Tariq ^ai   John, Walsh ^q   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h SOUTH TEES HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UK   (United Kingdom)

^j ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^k c o HIV i Base   (United Kingdom)

^l GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^m UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁿ LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

^p ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^q IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^r BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^s ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^t MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^u ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^v ADDENBROOKE S HOSPITAL   (United Kingdom)

^w KING S COLLEGE HOSPITAL   (United Kingdom)

^x NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST   (United Kingdom)

^y UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^z HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^aa Chair)   (United Kingdom)

^ab NORTH BRISTOL NHS TRUST   (United Kingdom)

^ac ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^ad SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^ae NHS LOTHIAN   (United Kingdom)

^af YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^ag BARTS HEALTH NHS TRUST   (United Kingdom)

^ah UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^ai ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

^aj UK COMMUNITY ADVISORY BOARD   (United Kingdom)

^ak ASHFORD AND ST PETER'S HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^al KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BLOOD; CLASSIFICATION; FEMALE; GENETICS; GENOTYPE; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MIDDLE AGED; MOLECULAR GENETICS; PHYLOGENY; VERY ELDERLY; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; VIRAL LOAD; YOUNG ADULT;

EID: 84901679825     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004112     Document Type: Article

References (89)

1. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, et al. (1996) Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma. Science 272: 1167-1170 doi:10.1126/science.272.5265.1167.
2. Fraser C, Hollingsworth TD, Chapman R, de Wolf F, Hanage WP, (2007) Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis. Proceedings of the National Academy of Sciences 104: 17441-17446 doi:10.1073/pnas.0708559104.
3. Langford SE, Ananworanich J, Cooper DA, (2007) Predictors of disease progression in HIV infection: a review. AIDS Res Ther 4: 11 doi:10.1186/1742-6405-4-11.
4. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1. N Engl J Med 342: 921-929 doi:10.1056/NEJM200003303421303.
5. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, et al. (2001) Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 17: 901-910 doi:10.1089/088922201750290023.
6. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates of HIV-1 Transmission Per Coital Act, by Stage of HIV-1 Infection, in Rakai, Uganda. J Infect Dis 191: 1403-1409 doi:10.1086/429411.
7. Steel CM, Beatson D, Cuthbert RJG, Morrison H, Ludlam CA, et al. (1988) HLA Haplotype A1 B8 DR3 as a Risk Factor for HIV-Related Disease. The Lancet 331: 1185-1188 doi:10.1016/S0140-6736(88)92009-0.
8. Kaslow RA, vanRaden M, Friedman H, Duquesnoy R, Marrari M, et al. (1990) A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection: A report from the Multicenter AIDS Cohort Study. The Lancet 335: 927-930 doi:10.1016/0140-6736(90)90995-H.
9. O'Brien SJ, Nelson GW, (2004) Human genes that limit AIDS. Nat Genet 36: 565-574 doi:10.1038/ng1369.
10. Tang J, Tang S, Lobashevsky E, Zulu I, Aldrovandi G, et al. (2004) HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. AIDS Res Hum Retroviruses 20: 19-25 doi:10.1089/088922204322749468.
11. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, et al. (2009) Common Genetic Variation and the Control of HIV-1 in Humans. PLoS Genet 5: e1000791 doi:10.1371/journal.pgen.1000791.
12. Salgado M, Brennan T, O'Connell K, Bailey J, Ray S, et al. (2010) Evolution of the HIV-1 nef gene in HLA-B*57 Positive Elite Suppressors. Retrovirology 7: 94 doi:10.1186/1742-4690-7-94.
13. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, et al. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2: 1240-1243 doi:10.1038/nm1196-1240.
14. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, et al. (1997) Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression. Science 277: 959-965 doi:10.1126/science.277.5328.959.
15. Pido-Lopez J, Whittall T, Wang Y, Bergmeier LA, Babaahmady K, et al. (2007) Stimulation of Cell Surface CCR5 and CD40 Molecules by Their Ligands or by HSP70 Up-Regulates APOBEC3G Expression in CD4+ T Cells and Dendritic Cells. J Immunol 178: 1671-1679.
16. Åsjö B, Albert J, Karlsson A, Morfeldt-Månson L, Biberfeld G, et al. (1986) Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. The Lancet 328: 660-662 doi:10.1016/S0140-6736(86)90169-8.
17. Fenyo EM, Morfeldt Manson L, Chiodi F, Lind B, von Gegerfelt A, et al. (1988) Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. JVirol 62: 4414-4419.
18. Fiore JR, Calabro ML, Angarano G, De Rossi A, Fico C, et al. (1990) HIV-1 variability and progression to AIDS: a longitudinal study. J Med Virol 32: 252-256.
19. Hutchinson CM, Wilson C, Reichart CA, Marsiglia VC, Zenilman JM, et al. (1991) CD4 Lymphocyte Concentrations in Patients With Newly Identified HIV Infection Attending STD Clinics: Potential Impact on Publicly Funded Health Care Resources. JAMA 266: 253-256 doi:10.1001/jama.1991.03470020079036.
20. Weiss PJ, Brodine SK, Goforth RR, Kennedy CA, Wallace MR, et al. (1992) Initial Low CD4 Lymphocyte Counts in Recent Human Immunodeficiency Virus Infection and Lack of Association with Identified Coinfections. The Journal of Infectious Diseases 166: 1149-1153.
21. Gorham ED, Garland FC, Mayers DL, Goforth RR, Brodine SK, et al. (1993) CD4 Lymphocyte Counts Within 24 Months of Human Immunodeficiency Virus Seroconversion: Findings in the US Navy and Marine Corps. Arch Intern Med 153: 869-876 doi:10.1001/archinte.1993.00410070055008.
22. Holmberg SD, Conley LJ, Luby SP, Cohn S, Wong LC, et al. (1995) Recent Infection with Human Immunodeficiency Virus and Possible Rapid Loss of CD4 T Lymphocytes. JAIDS Journal of Acquired Immune Deficiency Syndromes 9: 291-296.
23. Veugelers PJ, Page KA, Tindall B, Schechter MT, Moss AR, et al. (1994) Determinants of HIV Disease Progression among Homosexual Men Registered in the Tricontinental Seroconverter Study. American Journal of Epidemiology 140: 747-758.
24. O'Brien TR, Hoover DR, Rosenberg PS, Chen B, Detels R, et al. (1995) Evalution of Secular Trends in CD4+ Lymphocyte Loss among Human Immunodeficiency Virus Type 1 (HIV-1)-infected Men with Known Dates of Seroconversion. American Journal of Epidemiology 142: 636-642.
25. Galai N, Lepri AC, Vlahov D, Pezzotti P, Sinicco A, et al. (1996) Temporal Trends of Initial CD4 Cell Counts Following Human Immunodeficiency Virus Seroconversion in Italy, 1985-1992. American Journal of Epidemiology 143: 278-282.
26. Keet IPM, Veugelers PJ, Koot M, de Weerd MH, Roos MTL, et al. (1996) Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. AIDS 10: 1601-1602.
27. Carré N, Prins M, Meyer L, Brettle RP, Robertson JR, et al. (1997) Has the rate of progression to AIDS changed in recent years? AIDS 11: 1611-1618.
28. Sinicco A, Fora R, Raiteri R, Sciandra M, Bechis G, et al. (1997) Is the clinical course of HIV-1 changing? Cohort study. BMJ 314: 1232-1237.
29. Vanhems P, Lambert J, Guerra M, Hirschel B, Allard R, (1999) Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study. J Infect Dis 180: 1803-1808 doi:10.1086/315110.
30. Concerted Action on SeroConversion to AIDS and Death in Europe (2000) Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. The Lancet 355: 1131-1137 doi:doi: DOI: 10.1016/S0140-6736(00)02061-4.
31. CASCADE Collaboration (2003) Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion. J Acquir Immune Defic Syndr 34: 76-83.
32. Dorrucci M, Phillips AN, Longo B, Rezza G, (2005) The Italian Seroconversion Study (2005) Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002. AIDS 19: 331-335.
33. Müller V, Ledergerber B, Perrin L, Klimkait T, Furrer H, et al. (2006) Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS 20: 889-894.
34. Crum-Cianflone N, Eberly L, Zhang Y, Ganesan A, Weintrob A, et al. (2009) Is HIV Becoming More Virulent? Initial CD4 Cell Counts among HIV Seroconverters During the Course of the HIV Epidemic: 1985-2007. Clin Infect Dis 48: 1285-1292 doi:10.1086/597777.
35. Müller V, Maggiolo F, Suter F, Ladisa N, De Luca A, et al. (2009) Increasing Clinical Virulence in Two Decades of the Italian HIV Epidemic. PLoS Pathog 5: e1000454 doi:10.1371/journal.ppat.1000454.
36. Dorrucci M, Rezza G, Porter K, Phillips A, (2007) Temporal Trends in Postseroconversion CD4 Cell Count and HIV Load: The Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. The Journal of Infectious Diseases 195: 525-534 doi:10.1086/510911.
37. Herbeck JT, Müller V, Maust BS, Ledergerber B, Torti C, et al. (2012) Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission. AIDS 26: 193-205 doi:10.1097/QAD.0b013e32834db418.
38. Martinez-Picado J, Martínez MA, (2008) HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo. Virus Research 134: 104-123 doi:10.1016/j.virusres.2007.12.021.
39. Fenner F, Chapple PJ, (1965) Evolutionary changes in myxoma virus in Britain: An examination of 222 in naturally occurring strains obtained from 80 counties during the period October-November 1962. Journal of Hygiene 63: 175-185 doi:10.1017/S0022172400045083.
40. Anderson RM, May RM, (1979) Population biology of infectious diseases: Part I. Nature 280: 361-367 doi:10.1038/280361a0.
41. May RM, Anderson RM, (1983) Epidemiology and Genetics in the Coevolution of Parasites and Hosts. Proceedings of the Royal Society of London Series B, Biological Sciences 219: 281-313.
42. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, et al. (2000) Timing the ancestor of the HIV-1 pandemic strains. Science 288: 1789-1796.
43. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, et al. (2008) Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455: 661-664 doi:10.1038/nature07390.
44. Kanki PJ, Hamel DJ, Sankalé J, Hsieh C, Thior I, et al. (1999) Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression. The Journal of Infectious Diseases 179: 68-73 doi:10.1086/314557.
45. Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, et al. (2001) Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS 15: 293-299.
46. Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, et al. (2008) Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 197: 707-713 doi:10.1086/527416.
47. Van der Kuyl AC, Jurriaans S, Pollakis G, Bakker M, Cornelissen M, (2010) HIV RNA levels in transmission sources only weakly predict plasma viral load in recipients. AIDS 24: 1607-1608 doi:10.1097/QAD.0b013e32833b318f.
48. Hecht FM, Hartogensis W, Bragg L, Bacchetti P, Atchison R, et al. (2010) HIV RNA level in early infection is predicted by viral load in the transmission source. AIDS 24: 941-945 doi:10.1097/QAD.0b013e328337b12e.
49. Hollingsworth TD, Laeyendecker O, Shirreff G, Donnelly CA, Serwadda D, et al. (2010) HIV-1 Transmitting Couples Have Similar Viral Load Set-Points in Rakai, Uganda. PLoS Pathog 6: e1000876 doi:10.1371/journal.ppat.1000876.
50. Alizon S, von Wyl V, Stadler T, Kouyos RD, Yerly S, et al. (2010) Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load. PLoS Pathog 6: e1001123 doi:10.1371/journal.ppat.1001123.
51. Lynch M, (1991) Methods for the Analysis of Comparative Data in Evolutionary Biology. Evolution 45: 1065-1080.
52. Pagel M, (1999) Inferring the historical patterns of biological evolution. Nature 401: 877-884 doi:10.1038/44766.
53. Housworth EA, Martins EP, Lynch M, (2004) The phylogenetic mixed model. Am Nat 163: 84-96 doi:10.1086/380570.
54. Patterson HD, Thompson R, (1971) Recovery of Inter-Block Information When Block Sizes Are Unequal. Biometrika 58: 545-554 doi:10.1093/biomet/58.3.545.
55. Thompson R, Brotherstone S, White IMS, Thompson R, Brotherstone S, et al. (2005) Estimation of Quantitative Genetic Parameters. Phil Trans R Soc B 360: 1469-1477 doi:10.1098/rstb.2005.1676.
56. Hadfield JD, Nakagawa S, (2010) General quantitative genetic methods for comparative biology: phylogenies, taxonomies and multi-trait models for continuous and categorical characters. Journal of Evolutionary Biology 23: 494-508 doi:10.1111/j.1420-9101.2009.01915.x.
57. Gilmour AR, Gogel BJ, Cullis BR, Thompson R (2009) ASReml User Guide Release 3.0. Available: www.vsni.co.uk.
58. Henderson CR, (1976) A Simple Method for Computing the Inverse of a Numerator Relationship Matrix Used in Prediction of Breeding Values. Biometrics 32: 69-83 doi:10.2307/2529339.
59. Felsenstein J, (1985) Phylogenies and the Comparative Method. AmNat 125: 1-15.
60. Hansen TF, Martins EP, (1996) Translating Between Microevolutionary Process and Macroevolutionary Patterns: The Correlation Structure of Interspecific Data. Evolution 50: 1404-1417 doi:10.2307/2410878.
61. Davis TA (2006) Direct Methods for Sparse Linear Systems. SIAM. 229 p.
62. Freckleton RP, (2012) Fast likelihood calculations for comparative analyses. Methods in Ecology and Evolution 3: 940-947 doi:10.1111/j.2041-210X.2012.00220.x.
63. Leigh Brown AJ, Lycett SJ, Weinert L, Hughes GJ, Fearnhill E, et al. (2011) Transmission Network Parameters Estimated From HIV Sequences for a Nationwide Epidemic. J Infect Dis 204: 1463-1469 doi:10.1093/infdis/jir550.
64. The UK Collaborative HIV Cohort Steering Committee (2004) The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study. HIV Medicine 5: 115-124 doi:10.1111/j.1468-1293.2004.00197.x.
65. Stamatakis A, (2006) RAxML-VI-HPC: Maximum Likelihood-Based Phylogenetic Analyses with Thousands of Taxa and Mixed Models. Bioinformatics 22: 2688-2690 doi:10.1093/bioinformatics/btl446.
66. Stamatakis A, Blagojevic F, Nikolopoulos D, Antonopoulos C, (2007) Exploring New Search Algorithms and Hardware for Phylogenetics: RAxML Meets the IBM Cell. The Journal of VLSI Signal Processing 48: 271-286 doi:10.1007/s11265-007-0067-4.
67. Drummond AJ, Suchard MA, Xie D, Rambaut A, (2012) Bayesian Phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29: 1969-1973 doi:10.1093/molbev/mss075.
68. R Development Core Team (2011) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available: http://www.R-project.org.
69. Hadfield JD, (2010) MCMC Methods for Multi-Response Generalized Linear Mixed Models: The MCMCglmm R Package. Journal of Statistical Software 33: 1-22.
70. Hué S, Pillay D, Clewley JP, Pybus OG, (2005) Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci USA 102: 4425-4429.
71. O'Brien TR, Blattner WA, Waters D, Eyster M, Hilgartner MW, et al. (1996) Serum HIV-1 RNA Levels and Time to Development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 276: 105-110 doi:10.1001/jama.1996.03540020027025.
72. Nogueras M, Navarro G, Antón E, Sala M, Cervantes M, et al. (2006) Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more. BMC Infectious Diseases 6: 159 doi:10.1186/1471-2334-6-159.
73. Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, et al. (1998) Sex differences in HIV-1 viral load and progression to AIDS. The Lancet 352: 1510-1514 doi:10.1016/S0140-6736(98)02372-1.
74. Sterling TR, Lyles CM, Vlahov D, Astemborski J, Margolick JB, et al. (1999) Sex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters. J Infect Dis 180: 666-672 doi:10.1086/314967.
75. Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, et al. (2002) Does Patient Sex Affect Human Immunodeficiency Virus Levels? Clin Infect Dis 35: 313-322 doi:10.1086/341249.
76. Müller V, von Wyl V, Yerly S, Böni J, Klimkait T, et al. (2009) African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study. AIDS 23: 1269-1276 doi:10.1097/QAD.0b013e32832d4096.
77. Brown AE, Malone JD, Zhou SYJ, Lane JR, Hawkes CA, (1997) Human Immunodeficiency Virus RNA Levels in US Adults: A Comparison Based upon Race and Ethnicity. J Infect Dis 176: 794-797 doi:10.1086/517304.
78. Swindells S, Cobos DG, Lee N, Lien EA, Fitzgerald AP, et al. (2002) Racial/ethnic differences in CD4 T cell count and viral load at presentation for medical care and in follow-up after HIV-1 infection. AIDS 16: 1832-1834.
79. Boyd A, Murad S, O'Shea S, De Ruiter A, Watson C, et al. (2005) Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London. HIV Medicine 6: 59-65 doi:10.1111/j.1468-1293.2005.00267.x.
80. Health Protection Agency (2011) HIV in the United Kingdom: 2011 Report. London: Health Protection Services, Colindale. Available: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131685847.
81. Müller V, Fraser C, Herbeck JT, (2011) A Strong Case for Viral Genetic Factors in HIV Virulence. Viruses 3: 204-216 doi:10.3390/v3030204.
82. Lockett SF, Robertson JR, Brettle RP, Yap PL, Middleton D, et al. (2001) Mismatched Human Leukocyte Antigen Alleles Protect Against Heterosexual HIV Transmission. JAIDS Journal of Acquired Immune Deficiency Syndromes 27: 277-280.
83. Dorak MT, Tang J, Penman-Aguilar A, Westfall AO, Zulu I, et al. (2004) Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples. The Lancet 363: 2137-2139 doi:10.1016/S0140-6736(04)16505-7.
84. Hinkley T, Martins J, Chappey C, Haddad M, Stawiski E, et al. (2011) A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase. Nat Genet 43: 487-489 doi:10.1038/ng.795.
85. Ariën KK, Troyer RM, Gali Y, Colebunders RL, Arts EJ, et al. (2005) Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 19: 1555-1564.
86. Liu TF, Shafer RW, (2006) Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation. Clin Infect Dis 42: 1608-1618 doi:10.1086/503914.
87. Rhee S-Y, Gonzales MJ, Kantor R, Betts BJ, Ravela J, et al. (2003) Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Research 31: 298-303.
88. Shafer RW, (2006) Rationale and Uses of a Public HIV Drug-Resistance Database. The Journal of Infectious Diseases 194: S51-S58 doi:10.1086/505356.
89. Price MN, Dehal PS, Arkin AP, (2010) FastTree 2 - Approximately Maximum-Likelihood Trees for Large Alignments. PLoS ONE 5: e9490 doi:10.1371/journal.pone.0009490.